Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. (Q34262850)

1 August 2017

Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. (English)

1 reference

1 August 2017

Fa Liu

1

1 reference

1 August 2017

Jung-Eun Park

2

1 reference

1 August 2017

Wen-Jian Qian

3

1 reference

1 August 2017

Dan Lim

4

1 reference

1 August 2017

Andrej Scharow

5

1 reference

1 August 2017

Thorsten Berg

6

1 reference

1 August 2017

Michael B Yaffe

7

1 reference

1 August 2017

Kyung S Lee

8

1 reference

1 August 2017

Terrence R Burke

9

1 reference

1 August 2017

language of work or name

1 reference

8 May 2012

1 reference

1 August 2017

1 reference

1 August 2017

13

1 reference

1 August 2017

9

1 reference

1 August 2017

1291-1296

1 reference

Preparation of orthogonally protected (2S, 3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) as a phosphatase-stable phosphothreonine mimetic and its use in the synthesis of Polo-box domain-binding peptides

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Identification of High Affinity Polo-like Kinase 1 (Plk1) Polo-box Domain Binding Peptides Using Oxime-Based Diversification

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

PLK1 as an oncology target: current status and future potential

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

From Crystal Packing to Molecular Recognition: Prediction and Discovery of a Binding Site on the Surface of Polo-Like Kinase 1

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Peptoid-Peptide hybrid backbone architectures.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

The medicinal chemistry of peptides

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Peptoids as potential therapeutics.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

A pan-specific inhibitor of the polo-box domains of polo-like kinases arrests cancer cells in mitosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Promiscuous aggregate-based inhibitors promote enzyme unfolding

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

The growing applications of click chemistry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonists

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

The growing impact of click chemistry on drug discovery

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Design and pharmacology of peptoids and peptide-peptoid hybrids based on the melanocortin agonists core tetrapeptide sequence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Converting a peptide into a drug: strategies to improve stability and bioavailability

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Improving SH3 domain ligand selectivity using a non-natural scaffold

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Peptoids: a modular approach to drug discovery.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4536914

Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCBIC.201200206

A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCBIC.201200206

Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCBIC.201200206

Optimization of a solid-phase synthesis of a PNA monomer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22570300

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Peptoid-peptide hybrids as potent novel melanocortin receptor ligands

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22570300

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CBIC.201200206

1 reference

1 August 2017

1 reference

1 August 2017

1 reference